Last €88.76 EUR
Change Today +0.30 / 0.34%
Volume 5.5M
SAN On Other Exchanges
Symbol
Exchange
EN Paris
EN Paris
New York
OTC US
BrsaItaliana
Mexico
Frankfurt
Frankfurt
NASDAQ GM
As of 11:38 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gary J. Nabel M.D., Ph.D.

Chairman of the Strategic Development & Scientific Advisory Council, Chief Scientific Officer and Senior Vice President, Sanofi
AgeTotal Calculated CompensationThis person is connected to 17 board members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background*

Dr. Gary J. Nabel, M.D., Ph.D. has been the Chief Scientific Officer at Sanofi since November 2012 and has been its Senior Vice President since December 2012. Dr. Nabel served as Deputy to the President for Global Research & Development at Sanofi since November 2012. Dr. Nabel was Director of the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases at National Institutes of Health from 1999 to November 2012. Dr. Nabel served as Chairman ...

Read Full Background

Corporate Headquarters*

54, Rue La Boétie
Paris, Ile-de-France 75008

France

Phone: 33 1 53 77 40 00
Fax: --

Board Members Memberships*

Former Director

Education*

PhD 1980
Harvard University
Bachelor's Degree 1975
Harvard University
MD 1982
Harvard University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAN:FP €88.76 EUR +0.30

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.